HDAC3 and stroke disorder: HDAC3 appears to promote a pro-inflammatory response, as its knockout in microglia of mouse models of brain injury [83] and stroke [84], as well as its pharmacological inhibition in animal models of depression, stroke, and spinal cord injury (Table 2) attenuated inflammation, conferred neuroprotection and stimulated remyelination.